NCT05151081View on ClinicalTrials.gov

Overactive Bladder Syndrome

CompletedOBSERVATIONAL
Enrollment

87

Participants

Timeline

Start Date

February 3, 2020

Primary Completion Date

July 3, 2021

Study Completion Date

October 15, 2021

Conditions
Overactive Bladder SyndromeEnuresis, Nocturnal
Interventions
OTHER

basicly

Do not repeat information already included in arm/group descriptions.

Trial Locations (1)

34768

Hisar Intercontinental Hospital, Istanbul

All Listed Sponsors
lead

Hisar Intercontinental Hospital

OTHER

NCT05151081 - Overactive Bladder Syndrome | Biotech Hunter | Biotech Hunter